BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29660685)

  • 21. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
    Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
    Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Icariin ameliorates glycolytic dysfunction in Alzheimer's disease models by activating the Wnt/β-catenin signaling pathway.
    Liu J; Wei AH; Liu TT; Ji XH; Zhang Y; Yan F; Chen MX; Hu JB; Zhou SY; Shi JS; Jin H; Jin F
    FEBS J; 2024 May; 291(10):2221-2241. PubMed ID: 38400523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sialoglycoprotein Isolated from Eggs of Carassius auratus Ameliorates Osteoporosis: An Effect Associated with Regulation of the Wnt/β-Catenin Pathway in Rodents.
    Wang F; Wang Y; Zhao Y; Zhan Q; Yu P; Wang J; Xue C
    J Agric Food Chem; 2016 Apr; 64(14):2875-82. PubMed ID: 27023001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of DHA-enriched phosphatidylcholine and EPA-enriched phosphatidylcholine on ameliorating high bone turnover
    Fu M; Tian Y; Zhang T; Zhan Q; Zhang L; Wang J
    Food Funct; 2020 Nov; 11(11):10094-10104. PubMed ID: 33140795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma MicroRNAs Are Altered Early and Consistently in a Mouse Model of Tauopathy.
    Ryan B; Williams JM; Curtis MA
    Neuroscience; 2019 Jul; 411():164-176. PubMed ID: 31152932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of aquaporin1 activates the Wnt signaling pathway to improve cognitive function in a mouse model of Alzheimer's disease.
    Yu B; Zhang J; Li H; Sun X
    Gene; 2020 Sep; 755():144904. PubMed ID: 32540373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer's Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway.
    Machhi J; Sinha A; Patel P; Kanhed AM; Upadhyay P; Tripathi A; Parikh ZS; Chruvattil R; Pillai PP; Gupta S; Patel K; Giridhar R; Yadav MR
    Neurotox Res; 2016 May; 29(4):495-513. PubMed ID: 26797524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of CXXC5 function rescues Alzheimer's disease phenotypes by restoring Wnt/β-catenin signaling pathway.
    Yoon M; Kim H; Shin H; Lee H; Kang MJ; Park SH; Han G; Kim Y; Choi KY
    Pharmacol Res; 2023 Aug; 194():106836. PubMed ID: 37355147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reprogramming energetic metabolism in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Life Sci; 2018 Jan; 193():141-152. PubMed ID: 29079469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indirubin-3'-oxime reverses bone loss in ovariectomized and hindlimb-unloaded mice via activation of the Wnt/β-catenin signaling.
    Zahoor M; Cha PH; Min do S; Choi KY
    J Bone Miner Res; 2014; 29(5):1196-205. PubMed ID: 24243753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy.
    Vagnozzi AN; Giannopoulos PF; Praticò D
    Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of mouse models to study cell-to-cell transmission of pathological tau.
    Narasimhan S; Lee VMY
    Methods Cell Biol; 2017; 141():287-305. PubMed ID: 28882308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-fat, high-sugar, and high-cholesterol consumption does not impact tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology.
    Gratuze M; Julien J; Morin F; Calon F; Hébert SS; Marette A; Planel E
    Neurobiol Aging; 2016 Nov; 47():71-73. PubMed ID: 27565300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Icariin promotes osteogenic differentiation of rat bone marrow stromal cells by activating the ERα-Wnt/β-catenin signaling pathway.
    Wei Q; Zhang J; Hong G; Chen Z; Deng W; He W; Chen MH
    Biomed Pharmacother; 2016 Dec; 84():931-939. PubMed ID: 27764755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis.
    Peng J; Lai ZG; Fang ZL; Xing S; Hui K; Hao C; Jin Q; Qi Z; Shen WJ; Dong QN; Bing ZH; Fu DL
    PLoS One; 2014; 9(11):e112744. PubMed ID: 25394221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated levels of brain homocysteine directly modulate the pathological phenotype of a mouse model of tauopathy.
    Di Meco A; Li JG; Barrero C; Merali S; Praticò D
    Mol Psychiatry; 2019 Nov; 24(11):1696-1706. PubMed ID: 29728702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pin1 Knockout Mice: A Model for the Study of Tau Pathology in Alzheimer's Disease.
    Kondo A; Albayram O; Zhou XZ; Lu KP
    Methods Mol Biol; 2017; 1523():415-425. PubMed ID: 27975268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.
    Sepulveda-Diaz JE; Alavi Naini SM; Huynh MB; Ouidja MO; Yanicostas C; Chantepie S; Villares J; Lamari F; Jospin E; van Kuppevelt TH; Mensah-Nyagan AG; Raisman-Vozari R; Soussi-Yanicostas N; Papy-Garcia D
    Brain; 2015 May; 138(Pt 5):1339-54. PubMed ID: 25842390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Wnt/β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
    Wang Q; Huang X; Su Y; Yin G; Wang S; Yu B; Li H; Qi J; Chen H; Zeng W; Zhang K; Verkhratsky A; Niu J; Yi C
    Brain; 2022 Dec; 145(12):4474-4488. PubMed ID: 35788280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.